Addus Amends 8-K to Include Gentiva YTD Pro Forma Results

Rhea-AI Filing Summary

Addus HomeCare Corporation amended its Current Report to provide additional financial disclosure related to a completed acquisition. The company reports that on December 2, 2024 its subsidiary, Addus HealthCare, Inc., completed the acquisition of the personal care business of Curo Health Services, LLC (doing business as Gentiva). This Amendment No. 2 adds unaudited financial statements of the acquired business for the year-to-date ended December 1, 2024, and references an unaudited pro forma condensed combined statement of operations for the same period filed as Exhibit 99.1. The filing states that all other disclosures in the prior amended report remain unchanged.

Positive

• Acquisition completion disclosed: The company confirms Addus HealthCare completed the acquisition of Gentiva's personal care business on December 2, 2024.
• Supplemental financial disclosure: Unaudited financial statements for the acquired business for the year-to-date ended December 1, 2024 were added.
• Pro forma information filed: An unaudited pro forma condensed combined statement of operations for the YTD period is included as Exhibit 99.1.

Negative

• None.

Insights

M&A Specialist

TL;DR: Acquisition of Gentiva personal care business completed and supplemental financials filed to integrate reporting.

The filing confirms a completed acquisition by Addus HealthCare, Inc. and supplements prior disclosure with unaudited financial statements for the acquired business through December 1, 2024, plus an unaudited pro forma condensed combined statement of operations as Exhibit 99.1. This is a routine post-closing disclosure step to allow investors to see the acquired business's recent performance and the preliminary combined operating results. The amendment does not state transaction consideration, expected synergies, or audited results, so material financial impact cannot be assessed from this filing alone.

Financial Analyst

TL;DR: Additional unaudited and pro forma financial information provided; no new operational metrics or guidance included.

The report provides unaudited YTD financials for the Acquired Business and a pro forma condensed combined statement of operations, which helps modelers incorporate the acquisition into forecasts. The document explicitly notes all other disclosures remain unchanged. Because the amendment does not include audited statements, specific revenue, profit or balance sheet figures, or transaction consideration, investors lack the quantitative detail needed to evaluate the acquisition's effect on Addus's financials from this filing alone.

Form 8-K/A date of report 12-02-24 true 0001468328 0001468328 2024-12-02 2024-12-02

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K/A

(Amendment No. 2)

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): August 27, 2025 (December 2, 2024)

ADDUS HOMECARE CORPORATION

(Exact name of registrant as specified in its charter)

Delaware		001-34504		20-5340172
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

6303 Cowboys Way, Suite 600 Frisco, Texas				75034
(Address of principal executive offices)				(Zip Code)

(469) 535-8200

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d- 2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.001 par value per share		ADUS		The Nasdaq Stock Market, LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company. ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Explanatory Note

On December 2, 2024, Addus HomeCare Corporation (the “Company”) filed a Current Report on Form 8-K (the “Original Form 8-K”) with the Securities and Exchange Commission to report that, on December 2, 2024, Addus HealthCare, Inc., an Illinois corporation (“Addus HealthCare”), a wholly-owned subsidiary of the Company, completed its acquisition of the personal care business (the “Acquired Business”) of Curo Health Services, LLC, a Delaware limited liability company, which does business as Gentiva (“Gentiva”), and on February 14, 2025, the Company filed Amendment No.1 to the Original Form 8-K (together with the Original Form 8-K, the “Amended Form 8-K) to include certain audited and unaudited financial statements and unaudited pro forma combined financial statements of the Acquired Business. This Amendment No. 2 to the Current Report on Form 8-K amends the Amended Form 8-K to include in Item 9.01 as set forth below the unaudited financial statements of the Acquired Business for the year-to-date ended December 1, 2024. All other disclosures contained in the Amended Form 8-K remain unchanged.

Item 9.01 Financial Statements and Exhibits.

(a) Not applicable.

(b) Pro Forma Financial Information.

The unaudited pro forma condensed combined statement of operations for the year-to-date ended December 1, 2024, are filed herewith as Exhibit 99.1 to this report and incorporated herein by reference.

(c) Not applicable.

(d) Exhibits:

Exhibit No.		Description
99.1		Unaudited pro forma combined financial information and the related notes
104		Cover Page Interactive Data File (embedded within Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ADDUS HOMECARE CORPORATION
Date: August 27, 2025	By:	/s/ Brian Poff
		Brian Poff
		Chief Financial Officer

FAQ

What did Addus HomeCare report in this 8-K/A (ADUS)?

The amendment adds unaudited financial statements of the acquired Gentiva personal care business for the year-to-date ended December 1, 2024 and references an unaudited pro forma condensed combined statement of operations filed as Exhibit 99.1.

When was the Gentiva personal care business acquisition completed?

The filing states the acquisition by Addus HealthCare, Inc. was completed on December 2, 2024.

Does the amendment change other disclosures from the prior filing?

No. The filing explicitly states that all other disclosures in the previously amended report remain unchanged.

Are audited financial statements included for the acquired business?

No. The filing adds unaudited financial statements and an unaudited pro forma condensed combined statement of operations.

Where can I find the pro forma combined statement of operations?

The unaudited pro forma condensed combined statement of operations for the year-to-date ended December 1, 2024 is filed as Exhibit 99.1 to this report.